- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2023–2027 · research · R01
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism
Joao Xavier · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers
Neelam Tyagi · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Multicolor PET to interrogate cancer biology
Jan Grimm · Kettering University · funded by National Institutes of Health
2023 · career development · K99
Understand Non-canonical RAS Signaling in Clonal Hematopoietic Disorders
Sisi Chen · Kettering University · funded by National Institutes of Health
2023–2026 · research · R00
New approaches for leveraging single-cell data to identify disease-critical genes and gene sets
Kushal Kumar Dey · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers
Neelam Tyagi · Kettering University · funded by National Institutes of Health
2023–2026 · fellowship · F31
Investigating the role of melanoma-adipocyte cell junctions in heterotypic communication and tumor progression
Sarah Perlee · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
Ping Chi · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
TOX-driven CD8 T cell differentiation and dysfunction in tumors
Andrea Schietinger · Kettering University · funded by National Institutes of Health
2023–2024 · fellowship · F31
Investigating the role of melanoma-adipocyte cell junctions in heterotypic communication and tumor progression
Sarah Perlee · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Germline mutagenesis at meiotic double-strand breaks
Maria Jasin · Kettering University · funded by National Institutes of Health
2023–2030 · research · R35
Exploring the Role of Nitrogen Metabolism in Cancer
Craig B Thompson · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Multicolor PET to interrogate cancer biology
Jan Grimm · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
Therapeutic targeting of RTK protein granules in cancer
Asmin Tulpule · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer
Sohrab P Shah · Kettering University · funded by National Institutes of Health
2023–2025 · career development · K99
Investigating the interplay between senescence and T cell immunity
Riccardo Mezzadra · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2023–2024 · research · R03
Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy
Anthony Francis Yu · Kettering University · funded by National Institutes of Health
2023–2027 · research · R37
Probabilistic Multiscale Modeling of the Tumor Microenvironment
Wesley Tansey · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Selective interactome vulnerability across the Alzheimer’s disease spectrum
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Intestinal microbiome restoration in allogeneic stem cell transplantation
Doris Ponce · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
The natural killer cell response against mouse cytomegalovirus infection
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2023–2026 · research · R01
Origins and functions of pancreatic cancer-associated fibroblasts
Mara H. Sherman · Kettering University · funded by National Institutes of Health
2023–2028 · research · R37
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
Anaeze C Offodile · Kettering University · funded by National Institutes of Health
2023–2028 · training · T32
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)
Jonine L. Bernstein · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2023 · research · R01
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
Dmitriy Zamarin · Kettering University · funded by National Institutes of Health
2023–2026 · career development · K99
The role of the novel interface cell state in melanoma invasion
Miranda Victoria Hunter · Kettering University · funded by National Institutes of Health
2023–2025 · research · R21
Genomics of Renal Cancer in Patients of African Ancestry
Alison M. Taylor · Kettering University · funded by National Institutes of Health
2023 · career development · K08
Investigating High-Risk Epigenetic Modifying Alterations on JAK2VF Dependency and Fibrotic Progression in Myeloproliferative Neoplasms (MPNs)
Andrew Jeffrey Dunbar · Kettering University · funded by National Institutes of Health
2023–2026 · grant · Standard Grant
Collaborative Research: EPIIC: Enabling Meaningful External Research Growth in Emergent Technologies (EMERGE)
Diane Peters · Kettering University · funded by National Science Foundation
2023–2027 · research · R01
Investigating telomerase dynamics in live cells at a single-molecule level
Pascal Chartrand · Kettering University · funded by National Institutes of Health
2023–2025 · career development · K99
Causal determinants of drug resistance and metastasis in cancer with multimodal single cell data
Sohrab Salehi · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Intestinal microbiome restoration in allogeneic stem cell transplantation
Doris Ponce · Kettering University · funded by National Institutes of Health
2023–2026 · research · R01
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
Ross Leigh Cagan · Kettering University · funded by National Institutes of Health
2023–2024 · cooperative agreement · U01
Diversity Supplement: Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer
Andrea Cercek · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease
Viviane Tabar · Kettering University · funded by National Institutes of Health
2023–2028 · research · R25
Genomics Research Experience for Master's Students (GEMS) Fellowship
Katherine S Panageas · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Mechanisms of racial disparity in breast cancer-related lymphedema
Andrea Barrio · Kettering University · funded by National Institutes of Health